Product Overview: Dostiheal 0.
Dostiheal 0.25 mg is a selective dopamine agonist research compound manufactured by Healing Pharma, specifically formulated for laboratory investigation of D2 dopamine receptor mechanisms. This compound belongs to the ergot alkaloid derivative class and represents an important tool for researchers examining prolactin inhibition pathways and dopaminergic neurotransmission in controlled experimental settings. Scientists at Stroid UK Shop have access to this pharmaceutical-grade material for advanced biochemical studies investigating hypothalamic-pituitary axis modulation.
Laboratory Research Applications
Research teams studying prolactin regulation mechanisms frequently examine this compound’s interaction with D2 receptors in pituitary lactotroph cells. The 0.25 mg formulation provides precise dosing capabilities for titration studies examining dose-response relationships in cell culture experiments. Investigators researching Parkinson’s disease models evaluate dopamine agonist effects on motor function pathways, while reproductive endocrinology laboratories analyse prolactin suppression mechanisms relevant to hyperprolactinemia research. Studies examining miscellaneous research compounds often incorporate this material alongside other neuromodulatory agents. Researchers exploring neuroprotective pathways investigate ergot derivatives’ effects on oxidative stress markers, while pharmacokinetic studies examine bioavailability and receptor binding affinity parameters. Comparative analyses with SARMs and peptides provide valuable insights into receptor selectivity profiles across different compound classes.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Cabergoline |
| Strength | 0.25 mg per tablet |
| Manufacturer | Healing Pharma |
| CAS Number | 81409-90-7 |
| Molecular Formula | C₂₆H₃₇N₅O₂ |
| Molecular Weight | 451.60 g/mol |
| Storage Requirements | Room temperature, dry environment |
| Shelf Life | 24 months when stored properly |
Research Compliance Statement
This product is manufactured exclusively for in-vitro research applications and laboratory analysis purposes. Dostiheal 0.25 mg is not intended for human consumption, therapeutic use, or any clinical applications. Researchers must maintain appropriate laboratory safety protocols and ensure proper disposal of materials according to institutional guidelines. This compound should only be handled by qualified laboratory personnel with appropriate training in pharmaceutical research methodologies.
